The art of forging neurons: direct reprogramming of somatic cells into induced neuronal cells

e-Neuroforum ◽  
2013 ◽  
Vol 19 (2) ◽  
Author(s):  
M. Karow ◽  
B. Berninger
Keyword(s):  
Stem Cells ◽  
Neural Stem Cells ◽  
Neuronal Cells ◽  
Somatic Cells ◽  
Cell Types ◽  
Direct Conversion ◽  
Cellular Reprogramming ◽  
Direct Reprogramming ◽  
Brain Pericytes

AbstractCellular reprogramming has shed new light on the plasticity of terminally differentiated cells and unearthed novel strategies for cell-based therapies to treat neurological disor­ders. With accumulating knowledge of the programs underlying the genesis of the dis­tinct neural cell types, particularly the iden­tification of crucial transcription factors and microRNAs, reprogramming of somatic cells of different origins into induced neuronal cells or neural stem cells has been success­fully achieved. Starting with the general con­cept of reprogramming, we discuss three dif­ferent paradigms: (1) direct conversion of central nervous system (CNS) foreign cells such as skin fibroblasts into induced neuro­nal cells or neural stem cells; (2) transdiffer­entiation of CNS resident cells such as astro­cytes and brain pericytes into induced neuro­nal cells; (3) reprogramming of one neuronal subtype into another. The latter has already been successfully achieved in vivo during ear­ly brain development, providing a strong im­pulse to attempt direct reprogramming in si­tu for future brain repair.

Die Kunst des Neuronenschmiedens: Direkte Reprogrammierung somatischer Zellen in induzierte neuronale Zellen

e-Neuroforum ◽  
2013 ◽  
Vol 19 (2) ◽  
Author(s):  
Marisa Karow ◽  
Benedikt Berninger
Keyword(s):  
Stem Cells ◽  
Neural Stem Cells ◽  
Neuronal Cells ◽  
Somatic Cells ◽  
Cell Types ◽  
Direct Conversion ◽  
Cellular Reprogramming ◽  
Direct Reprogramming ◽  
Brain Pericytes

AbstractThe art of forging neurons: direct reprogramming of somatic cells into induced neu­ronal cells.Cellular reprogramming has shed new light on the plasticity of terminally differentiated cells and discloses novel strategies for cell-based therapies for neurological disorders. With accumulating knowledge of the programs underlying the genesis of the distinct neural cell types, especially with the identification of relevant transcription factors and microRNAs, reprogramming of somatic cells of different origins into induced neuronal cells or neural stem cells has been successfully achieved. Starting with the general con­cept of reprogramming we discuss here three different paradigms: 1) direct conversion of CNS-foreign cells such as skin fibroblasts into induced neuronal cells or neural stem cells; 2) transdifferentiation of CNS resident cells such as astrocytes and brain pericytes into induced neuronal cells; 3) reprogramming of one neuronal subtype into another. The latter has already been successfully achieved in vivo during early brain develop­ment, providing strong impulse for the attempt to succeed in direct reprogramming in situ for future brain repair.

Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation

2019 ◽  
Vol 19 (4) ◽  
pp. 248-254
Author(s):  
Marianne Lehmann ◽  
Martina Canatelli-Mallat ◽  
Priscila Chiavellini ◽  
Gloria M. Cónsole ◽  
Maria D. Gallardo ◽  
...  
Keyword(s):  
Stem Cells ◽  
Somatic Cell ◽  
Fluorescent Protein ◽  
Somatic Cells ◽  
Cell Types ◽  
Cell Reprogramming ◽  
Green Fluorescent ◽  
Original Cell

Background: Conventional cell reprogramming involves converting a somatic cell line into induced pluripotent stem cells (iPSC), which subsequently can be re-differentiated to specific somatic cell types. Alternatively, partial cell reprogramming converts somatic cells into other somatic cell types by transient expression of pluripotency genes thus generating intermediates that retain their original cell identity, but are responsive to appropriate cocktails of specific differentiation factors. Additionally, biological rejuvenation by partial cell reprogramming is an emerging avenue of research. Objective: Here, we will briefly review the emerging information pointing to partial reprogramming as a suitable strategy to achieve cell reprogramming and rejuvenation, bypassing cell dedifferentiation. Methods: In this context, regulatable pluripotency gene expression systems are the most widely used at present to implement partial cell reprogramming. For instance, we have constructed a regulatable bidirectional adenovector expressing Green Fluorescent Protein and oct4, sox2, klf4 and c-myc genes (known as the Yamanaka genes or OSKM). Results: Partial cell reprogramming has been used to reprogram fibroblasts to cardiomyocytes, neural progenitors and neural stem cells. Rejuvenation by cyclic partial reprogramming has been achieved both in vivo and in cell culture using transgenic mice and cells expressing the OSKM genes, respectively, controlled by a regulatable promoter. Conclusion: Partial reprogramming emerges as a powerful tool for the genesis of iPSC-free induced somatic cells of therapeutic value and for the implementation of in vitro and in vivo rejuvenation keeping cell type identity unchanged.

scholarly journals Efficient and Rapid generation of neural stem cells by direct conversion Fibroblasts with A Single microRNA

2021 ◽  
Author(s):  
yuesi wang ◽  
Yuanyuan Li ◽  
Jing Sun ◽  
Tingting Xu ◽  
Xiaobin Weng ◽  
...  
Keyword(s):  
Stem Cells ◽  
Neural Stem Cells ◽  
High Efficiency ◽  
Disease Modeling ◽  
System Development ◽  
Direct Conversion ◽  
Tumor Formation ◽  
Low Efficiency

Neural stem cells (NSCs) have great potential in the application of neurodegenerative disease therapy, drug screening and disease modeling. NSC can be generated by reprogramming from terminally differentiated cells with transcription factors or small molecules. However, current methods for producing NSCs involve the danger of integrating foreign genes into the genome and the problem of low efficiency. Here, we report an efficient method to generate NSCs from human skin-derived fibroblasts with microRNA (mir-302a) in 2-3 days. The induced NSCs (iNSCs) have more than 90% of purity. Their morphology is similar to regular NSCs, expressing key markers including Nestin, Pax6 and Sox2, and can be expanded for more than 20 passages in vitro. They can also differentiate into functional neuron progeny, astrocytes and oligodendrocytes as well. Those cells can elicit action potential, can be xeno-transplanted into the brain of immune-deficient mice, and can survive and differentiate in vivo without tumor formation. This study shows that a single part of pluripotency-inducing mir-302 cluster can drive fibroblasts reprogramming, providing a general platform for high-efficiency generation of individual-specific human NSCs for studies of neuron system development and regenerative cell therapy.

scholarly journals Rapid and Efficient Direct Conversion of Human Adult Somatic Cells into Neural Stem Cells by HMGA2/let-7b

Cell Reports ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. 441-452 ◽  
Author(s):  
Kyung-Rok Yu ◽  
Ji-Hee Shin ◽  
Jae-Jun Kim ◽  
Myung Guen Koog ◽  
Jin Young Lee ◽  
...  
Keyword(s):  
Stem Cells ◽  
Neural Stem Cells ◽  
Somatic Cells ◽  
Direct Conversion ◽  
Human Adult

scholarly journals De Novo Human Cardiac Myocytes for Medical Research: Promises and Challenges

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Veronique Hamel ◽  
Kang Cheng ◽  
Shudan Liao ◽  
Aizhu Lu ◽  
Yong Zheng ◽  
...  
Keyword(s):  
Stem Cells ◽  
Cardiac Myocytes ◽  
Disease Modeling ◽  
De Novo ◽  
Somatic Cells ◽  
Embryonic Stem ◽  
Cellular Reprogramming ◽  
Great Promise

The advent of cellular reprogramming technology has revolutionized biomedical research. De novo human cardiac myocytes can now be obtained from direct reprogramming of somatic cells (such as fibroblasts), from induced pluripotent stem cells (iPSCs, which are reprogrammed from somatic cells), and from human embryonic stem cells (hESCs). Such de novo human cardiac myocytes hold great promise for in vitro disease modeling and drug screening and in vivo cell therapy of heart disease. Here, we review the technique advancements for generating de novo human cardiac myocytes. We also discuss several challenges for the use of such cells in research and regenerative medicine, such as the immature phenotype and heterogeneity of de novo cardiac myocytes obtained with existing protocols. We focus on the recent advancements in addressing such challenges.

scholarly journals De novo generation of HSCs from somatic and pluripotent stem cell sources

Blood ◽  
2015 ◽  
Vol 125 (17) ◽  
pp. 2641-2648 ◽  
Author(s):  
Linda T. Vo ◽  
George Q. Daley
Keyword(s):  
Stem Cells ◽  
Disease Modeling ◽  
De Novo ◽  
Cell Types ◽  
Direct Conversion ◽  
Cellular Reprogramming ◽  
Directed Differentiation ◽  
Hematopoietic Stem ◽  
Cell Sources

Abstract Generating human hematopoietic stem cells (HSCs) from autologous tissues, when coupled with genome editing technologies, is a promising approach for cellular transplantation therapy and for in vitro disease modeling, drug discovery, and toxicology studies. Human pluripotent stem cells (hPSCs) represent a potentially inexhaustible supply of autologous tissue; however, to date, directed differentiation from hPSCs has yielded hematopoietic cells that lack robust and sustained multilineage potential. Cellular reprogramming technologies represent an alternative platform for the de novo generation of HSCs via direct conversion from heterologous cell types. In this review, we discuss the latest advancements in HSC generation by directed differentiation from hPSCs or direct conversion from somatic cells, and highlight their applications in research and prospects for therapy.

scholarly journals Brain Tumour Stem Cells and Neural Stem Cells: Still Explored by the Same Approach?

2008 ◽  
Vol 36 (5) ◽  
pp. 890-895 ◽  
Author(s):  
W Liu ◽  
G Shen ◽  
Z Shi ◽  
F Shen ◽  
X Zheng ◽  
...  
Keyword(s):  
Stem Cells ◽  
Growth Factor ◽  
Neural Stem Cells ◽  
Brain Tumour ◽  
Malignant Gliomas ◽  
Cell Types ◽  
Accurate Definition ◽  
Marker Expression ◽  
Definition Of

Brain tumour stem cells (BTSCs) are chiefly responsible for the in vivo long-term growth and recurrence of malignant gliomas and may be a potential treatment target. They resemble neural stem cells (NSCs), so their self-renewal and differentiation are currently investigated by the same methods used to study NSCs. There are, however, essential differences between these cell types: in many cases the marker expression pattern of BTSCs does not match the CD133+/NSE−/FAP− pattern of NSCs; BTSC tumourigenicity is independent of marker expression; and while attachment, serum-containing medium and withdrawal of mitogens (epidermal growth factor [EGF] and basic fibroblast growth factor [bFGF]) are essential to induce NSCs to differentiate, they do not affect BTSC tumourigenicity. Evidence implies that research on the renewal and differentiation of BTSCs should be orientated towards tumourigenicity and is essentially a pharmaceutical problem. Such an approach may contribute to the development of an accurate definition of BTSCs and to the search for selective differentiation-inducing drugs for BTSCs.

scholarly journals Polymorphic dynamics of ribosomal proteins gene expression during somatic cell reprogramming and their differentiation in to specialized cells-types

2017 ◽  
Author(s):  
Prashanth Kumar Guthikonda ◽  
Sumitha Prameela Bharathan ◽  
Janakiram Rayabaram ◽  
Trinadha Rao Sornapudi ◽  
Sailu Yellaboina ◽  
...  
Keyword(s):  
Gene Expression ◽  
Stem Cells ◽  
Ribosomal Protein ◽  
Ribosomal Proteins ◽  
Somatic Cells ◽  
Embryonic Stem ◽  
Cell Types ◽  
Dermal Fibroblasts ◽  
Great Promise

AbstractFactor induced pluripotent stem cells (iPSCs) offer great promise in regenerative medicine. However, accumulating evidence suggests that iPSCs are heterogeneous in comparison with embryonic stem cells (ESCs), and that is attributed to various genetic and epigenetic states of donor cells. In the light of the discovery of cell-type specialized ribosomal protein composition, its role as the cells transit through different stages of reprogramming and when iPSCs differentiate into specialized cell-types has not been explored to understand its influence in the reprogramming and differentiation process and outcome. By re-analyzing the publicly available gene expression datasets among ESCs, various sources of iPSCs and somatic cells and by studying the ribosomal protein gene expression during different stages of reprogramming of somatic cells and different passages of established iPSCs we found distinct patterns of their expression across multiple cell-types. We experimentally validated these results on the cells undergoing reprogramming from human dermal fibroblasts. Finally, by comparing publicly available data from iPSCs, iPSCs derived specialized cells and it’s in vivo counterparts, we show alterations in ribosomal gene expression during differentiation of specialized cells from iPSCs which may have Implications in the context of ribosomopathies. Our results provide an informatics framework for researchers in efficient generation of iPSCs that are equivalent to ESCs.

Sign in / Sign up

Export Citation Format

Share Document